Preclinical evaluation of the mTOR inhibitor, temsirolimus, in combination with the epothilone B analog, ixabepilone in renal cell carcinoma.

von Roemeling, Christina A; Marlow, Laura A; Kennedy, William P; Kennedy, Gregory T; Copland, John A; Menefee, Michael E

von Roemeling, Christina A; Marlow, Laura A; Kennedy, William P; Kennedy, Gregory T; Copland, John A; Menefee, Michael E.

Afiliación

von Roemeling CA; Department of Cancer Biology, Mayo Clinic College of Medicine 4500 San Pablo Road, Jacksonville, Florida, 32224.

Am J Cancer Res ; 3(4): 390-401, 2013.

Article en En | MEDLINE | ID: mdl-23977448

Palabras clave

Renal cell carcinoma; combination therapy; ixabepilone; mTOR inhibitor; microtubule stabilizer; temsirolimus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2013 Tipo del documento: Article